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FROM THE ARCHIVE
Kicking off adaptive immunity: the discovery of dendritic cells
In 1973, Ralph Steinman and Zanvil Cohn discovered an unusual looking 
population of cells with an unprecedented ability to activate naive T cells. 
Dubbed “dendritic cells,” these cells are now known as the primary instigators 
of adaptive immunity.
The clonal selection theory, proposed 
by Frank Macfarlane Burnet in 1957, 
posited that lymphocytes proliferate in 
response to antigens only if the antigen 
matches their receptor (1). But in the 
following decade, a big unknown re-
mained: how was the antigen presented 
to initiate the response?
During his medical training at Har-
vard University and the Massachusetts 
General Hospital, Steinman felt that the 
ability to understand and manipulate this 
initiation step was essential for develop-
ing new approaches to treating disease. 
“The theory at the time was that lym-
phocytes had receptors for antigens, 
which would respond on contact. But 
that clearly wasn’t enough,” he says, as 
simply adding a specific antigen did not 
elicit a primary immune response.
A new cell type
In 1966, Robert Mishell and Richard 
Dutton (Scripps Research Institute) 
added sheep red blood cells to a suspen-
sion of mouse spleen cells, generating the 
first in vitro primary antibody response 
(2). Others soon reported that this re-
sponse required the presence of a pool of 
splenic accessory cells, of which a large 
component was macrophages (3).
In 1970 Steinman began a post-doc-
toral fellowship at Rockefeller University 
with Zanvil Cohn, who was conducting 
pioneering studies on how macrophages 
catabolize microbes. Steinman decided 
to take a closer look at these splenic ac-
cessory cells. Using phase-contrast light 
microscopy, he found a small number of 
extensively branched, motile and mito-
chondria-rich cells mixed in with the 
expected macrophages.
“Dr. Cohn had probably more ex-
perience than anyone working with 
macrophages,” Steinman says. “We 
realized that these just didn’t look or 
behave like any other cells.” Because of 
the cells’ unique morphology, the pair 
dubbed them “dendritic cells” (DCs). 
Steinman published the phenotypic and 
functional characterization of DCs in 
two papers in the Journal of Experimental 
Medicine (4, 5).
From form to function
Steinman hypothesized that DCs were 
key immune response initiators, an idea 
that did not initially gain much support. 
“There was a lot of debate as to 
whether these cells were real or an arti-
fact,” says Antonio Lanzavecchia (Insti-
tute for Research in Biomedicine, 
Bellinzona, Switzerland). “They seemed 
to be too rare to be relevant.”
Steinman and colleagues character-
ized the proteins expressed on the surface 
of the DCs, which gave hints about their 
function. One major clue was the high-
level expression of major histocompati-
bility complex (MHC) proteins, such as 
Ia antigens (6), which later proved to be 
required for antigen presentation to T 
cells. Using the mixed leukocyte reac-
tion, a well-known technique used to 
mimic T cell–mediated rejection of do-
nor tissue during transplantation, Stein-
man showed that DCs could initiate the 
reaction and were 100 to 1,000 times 
more potent than bulk spleen cells (7).
Steinman’s team, and later others, 
showed that DCs were equally potent 
at stimulating both T cell cytotoxicity 
and antibody responses (8, 9). Subse-
quent studies described DC matura-
tion—the process by which immature 
DCs, which capture antigens in periph-
eral tissues, become efficient initiators 
of immunity (10, 11).
“Up till then [DCs were] a bit of an 
esoteric interest in the lab,” says Sia-
mon Gordon (Oxford University), then 
a postgraduate fellow in Cohn’s lab. 
But their potency suggested that only 
DCs could present antigens to naive 
lymphocytes. And many other re-
searchers soon confirmed their function 
as the immune system’s primary anti-
gen-presenting cells.
A new field explodes
Steinman, Kayo Inaba (Kyoto Univer-
sity), Gerold Schuler (University of Er-
langen), Jacques Banchereau (Baylor 
Institute for Immunology Research), 
Lanzavecchia, and others went on to 
develop techniques to grow DCs, 
eliminating the arduous task of purify-
ing them from lymphoid organs. This 
work set the stage for current research 
on the regulation of DC function and 
the design of DC-based vaccines for 
HIV and cancers.
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Phase-contrast image of a dendritic cell (4).